Mode
Text Size
Log in / Sign up
Phase 3 Completed N=70 Randomized Double-blind Treatment

Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment

Inflammation of Mouth · Acute Mucous Inflammation
Source: ClinicalTrials.gov NCT02536781 ↗
Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcomePrimary: Wound Size (mm^2) Reduction — 11.26; 8.92 mm^2
◆ Published Evidence
Highly cited
120citations · ~7 / year
Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2009 · High-confidence link

Summary

The purpose of this study is to compare the oral inflammatory reduction effect caused from orthodontic treatment of anthocyanin and placebo mouthrinse.

Linked Publications (2)

  • Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2009 · 120 citations · High-confidence link
  • Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.
    Clinical cancer research : an official journal of the American Association for Cancer Research · 2008 · 115 citations · Open access · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Wound Size (mm^2) Reduction
11.26; 8.92
SECONDARY
VAS Scores Range From 0 (no Pain) to 10 (Severe Pain)
1.53; 0.96

Eligibility Criteria

Inclusion Criteria

  • Male and/or females between the ages of 18 and 35 with oral inflammation, investigated by a dentist, caused by orthodontic devices.
  • The inflammatory lesions are occurred at labial and/or buccal mucosa.
  • Be able to communicate well with the investigator and to comply with the requirements of the entire study.
  • Not participate in other project(s).
  • Be willingness to give written informed consent (prior to any study-related procedures being performed) and to be able to adhere to the study restrictions and examination schedule.

Exclusion Criteria

  • - Have the persistent inflammatory lesions and/or ulcers that cannot be healed more than 2 weeks or the inflammation that may lead to be oral cancer.
  • Have severe oral inflammation or the inflammation occur from ongoing head and neck chemotherapy or serious oral inflammatory such as periodontitis and oral lichen planus.
  • Taking steroid or applying topical steroid within or 7 days before participated in this study.
  • Have a history of allergy or hypersensitivity to any red, blue, or purple color fruits and vegetables such as berry groups.
  • Patients with auto-immune diseases or diseases that related to wound healing process such as diabetes.
  • Patients that cannot meet the follow up or drop out of the experiments.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02536781) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search